Fucosylated exosomal miRNAs as promising biomarkers for the diagnosis of early lung adenocarcinoma

BACKGROUND: Considering the absence of apparent symptoms at the early stage, most patients with lung adenocarcinoma (LUAD) present at an advanced stage, leading to a dismal 5-year survival rate of <20%. Thus, finding perspective non-invasive biomarkers for early LUAD is very essential. METHODS: W...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Xiongfeng, Yu, Lili, Hao, Kun, Yin, Xiaoqing, Tu, Mingshu, Cai, Liqing, Zhang, Liangming, Pan, Xiaojie, Gao, Qi, Huang, Yi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9414872/
https://www.ncbi.nlm.nih.gov/pubmed/36033494
http://dx.doi.org/10.3389/fonc.2022.935184

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9414872/
https://www.ncbi.nlm.nih.gov/pubmed/36033494
http://dx.doi.org/10.3389/fonc.2022.935184

Ejemplares similares